Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus
Clinical trial NCT02445911 · COMPLETED
Trial details
- NCT number
- NCT02445911
- Sponsor
- Kaneq Bioscience Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-02-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.